TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. Still on Track?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to reduce its outstanding debt and tout new products with income potential.

    Read more »

    The Motley Fool
    Investing

    3 Drug and Nutrition Stocks That Belong in Your TFSA

    Stocks such as Jamieson Wellness Inc. (TSX:JWEL) offer the potential for explosive growth going forward.

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Sell its Way to Success?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYXE:VRX) will see it revenue drop as it sells assets to pay off debt. Can it…

    Read more »

    Investing

    3 Turnaround Stocks, 3 Massive Opportunities

    BlackBerry Ltd. (TSX:BB)(NYSE:BB) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have big upside remaining and good early signs of a comeback.

    Read more »

    The Motley Fool
    Investing

    Has Valeant Pharmaceuticals Intl Inc. Proven it Belongs in Your TFSA?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could once again be a market-beating stock, but are the risks still too high?

    Read more »

    The Motley Fool
    Investing

    New Incentive Program at Valeant Pharmaceuticals Intl Inc. Signals a New Culture That Investors Can Stand by

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is doing the right things to regain shareholders' trust.

    Read more »

    The Motley Fool
    Investing

    Better Turnaround Stock: Valeant Pharmaceuticals Intl Inc. vs. Home Capital Group Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has big company-specific risk due to its highly levered balance sheet, but it's attempting to…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Q4 Earnings Review: Hold on Tight

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) beat fourth-quarter earnings estimates, but it missed on revenues.

    Read more »

    The Motley Fool
    Dividend Stocks

    Is Valeant Pharmaceuticals Intl Inc. Next up on Warren Buffett’s Shopping List?

    Last week Warren Buffett made an announcement that shocked the market. Does the world's most famous investor have his sights…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Sure Has Fight in it

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to manage its debt, but will its product-development pipeline be enough to help it…

    Read more »

    win
    Tech Stocks

    Checklist: 4 Variables to Help us Find a Winning Stock

    Here's a checklist to ensure superior stock selection. CGI Group Inc. (TSX:GIB.A)(NYSE:GIB) is among top stocks that rank favourably.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Get Ready for a Massive Opportunity

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is gearing up to provide end-of-year results and guidance updates in two weeks.

    Read more »